|
Volumn 6, Issue 5, 1997, Pages 547-550
|
Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas
a a a a a a a a a a |
Author keywords
Antidiabetic agent; Biohybrid artificial pancreas; Islet xeno transplantation; Troglitazone (CS 045)
|
Indexed keywords
AGAROSE;
CARBOXYMETHYLCELLULOSE;
GLUCOSE;
HEXADIMETHRINE BROMIDE;
INSULIN;
ORAL ANTIDIABETIC AGENT;
POLYSTYRENESULFONIC ACID;
STREPTOZOCIN;
TROGLITAZONE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ARTIFICIAL PANCREAS;
CONTROLLED STUDY;
GLUCOSE BLOOD LEVEL;
GRAFT SURVIVAL;
HYBRID;
INSULIN RESPONSE;
INSULIN SENSITIVITY;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
INTRAVENOUS GLUCOSE TOLERANCE TEST;
MALE;
MICROENCAPSULATION;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
RAT;
STREPTOZOCIN DIABETES;
XENOGRAFT;
ANIMALS;
BLOOD GLUCOSE;
CAPSULES;
CHROMANS;
DIABETES MELLITUS, EXPERIMENTAL;
GLUCOSE TOLERANCE TEST;
GRAFT SURVIVAL;
HYPOGLYCEMIC AGENTS;
ISLETS OF LANGERHANS TRANSPLANTATION;
MALE;
MICE;
MICE, INBRED BALB C;
PANCREAS, ARTIFICIAL;
RATS;
RATS, SPRAGUE-DAWLEY;
THIAZOLES;
THIAZOLIDINEDIONES;
TRANSPLANTATION, HETEROLOGOUS;
ANIMALIA;
|
EID: 12644305890
PISSN: 09636897
EISSN: None
Source Type: Journal
DOI: 10.1016/S0963-6897(97)00075-4 Document Type: Article |
Times cited : (2)
|
References (8)
|